IRBESARTAN | A091236 | ALEMBIC PHARMACEUTICALS LTD
Highest NADAC/Unit
$0.1555
per ea
Lowest NADAC/Unit
$0.0827
per ea
Brand NDCs
0
Generic NDCs
8
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 62332004390IRBESARTAN 300 MG TABLET | $0.1555 | EA | Generic | — | 2026-08-19 |
| 62332004371IRBESARTAN 300 MG TABLET | $0.1555 | EA | Generic | — | 2026-08-19 |
| 62332004330IRBESARTAN 300 MG TABLET | $0.1555 | EA | Generic | — | 2026-08-19 |
| 62332004290IRBESARTAN 150 MG TABLET | $0.1109 | EA | Generic | — | 2026-08-19 |
| 62332004230IRBESARTAN 150 MG TABLET | $0.1109 | EA | Generic | — | 2026-08-19 |
| 62332004271IRBESARTAN 150 MG TABLET | $0.1109 | EA | Generic | — | 2026-08-19 |
| 62332004130IRBESARTAN 75 MG TABLET | $0.0827 | EA | Generic | — | 2026-08-19 |
| 62332004190IRBESARTAN 75 MG TABLET | $0.0827 | EA | Generic | — | 2026-08-19 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.